2026年1月1日,Medicare的新药品定价规则将10种关键药品的价格削减38%至79%。 On Jan. 1, 2026, Medicare's new drug pricing rules cut prices for 10 key drugs by 38% to 79%.

2026年1月1日,第一次谈判达成的医保药品价格根据《降低通货膨胀法》生效,为10种广泛使用的药品规定了最高公平价格。 On January 1, 2026, the first negotiated Medicare drug prices took effect under the Inflation Reduction Act, setting maximum fair prices for 10 widely used medications. Eliquis、Januvia、Insulins Fiasp和Novolog等药物的价格比清单价格低56%至79%,Eliquis每月从521美元降至231美元。 Prices for drugs like Eliquis, Januvia, and insulins Fiasp and Novolog dropped 56% to 79% below list prices, with Eliquis falling from $521 to $231 per month. Imbruvica看到最小的剪切 38%。 Imbruvica saw the smallest cut at 38%. 医疗保健中心和医疗保健服务中心规定了约束性价格,但受益人的实际储蓄因D部分或医疗保健福利计划而异。 The Centers for Medicare and Medicaid Services established binding prices, but actual savings for beneficiaries vary by Part D or Medicare Advantage plan. 该方案旨在减少医疗保健计划支出,提高长期可持续性。 The program aims to reduce Medicare spending and improve long-term sustainability.